Targeting solid tumors with GDT002, a first-in-class γδTCR-based T cell therapy

GDT002 - Gadeta

pamidronate disodium - Generic mfg.

https://www.abstractsonline.com/pp8/#!/10517/presentation/16738

Esther Drent, Andrea Bisso, Sjoerd Baardman, Dagmar Verweij, Estefania Salcedo, Chris Coomans, Steven Braem, Sander Van de Weg, Sara Melief, Haakan Norell, Marleen Van Loenen, Stefania Gobessi, Mark Throsby

Mar 9, 2022